Evidence map›Paper›PMID 41301717›Full record

ArticleBiomedicines2025

Interaction of Clinical Factors Modestly Predict Anti-TNF-Alpha Antibody Formation in a Real-World Cohort of Inflammatory Bowel Disease Patients.

Krisztián Kovács, Petra Nagypál, Barna Vásárhelyi, Antal Dezsőfi-Gottl, Nóra Béres, Pál Miheller, Ákos Iliás, Anna Balogh, Bence Prehoda, Luca Tóbi and 2 more

Abstract read
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Krisztián KovácsDepartment of Laboratory Medicine, Semmelweis University, 1089 Budapest, Hungary.
Petra NagypálPaediatric Centre, Semmelweis University, 1083 Budapest, Hungary.ORCID 0009-0002-9663-0666
Barna VásárhelyiDepartment of Laboratory Medicine, Semmelweis University, 1089 Budapest, Hungary.
Antal Dezsőfi-GottlPaediatric Centre, Semmelweis University, 1083 Budapest, Hungary.
Nóra BéresPaediatric Centre, Semmelweis University, 1083 Budapest, Hungary.
Pál MihellerDepartment of Surgery, Transplantation and Gastroenterology, Semmelweis University, 1082 Budapest, Hungary.
Ákos IliásDepartment of Internal Medicine and Oncology, Semmelweis University, 1088 Budapest, Hungary.
Anna BaloghPaediatric Centre, Semmelweis University, 1083 Budapest, Hungary.ORCID 0009-0004-1653-0388
Bence PrehodaPaediatric Centre, Semmelweis University, 1083 Budapest, Hungary.
Luca TóbiPaediatric Centre, Semmelweis University, 1083 Budapest, Hungary.
Attila SzabóPaediatric Centre, Semmelweis University, 1083 Budapest, Hungary.
Áron CsehPaediatric Centre, Semmelweis University, 1083 Budapest, Hungary.ORCID 0000-0003-1659-3173

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adalimumabantidrug antibodiesCrohn’s diseaseELISAimmunogenicityinflammatory bowel diseaseinfliximabulcerative Colitis

Identifiers

PMID41301717
PMCPMC12650685

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.